PFS Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2K Sell
156
-38
-20% -$3.06K ﹤0.01% 362
2026
Q1
$16.8K Sell
194
-38
-16% -$3.64K 0.01% 299
2025
Q4
$22.3K Buy
232
+2
+0.9% +$194 0.01% 272
2025
Q3
$21.9K Buy
230
+1
+0.4% +$92 0.01% 260
2025
Q2
$19.9K Buy
229
+114
+99% +$9.67K 0.01% 246
2025
Q1
$10.3K Buy
115
+1
+0.9% +$89 0.01% 285
2024
Q4
$9.08K Buy
114
+1
+0.9% +$87 ﹤0.01% 299
2024
Q3
$10.2K Buy
113
+1
+0.9% +$84 0.01% 284
2024
Q2
$8.8K Buy
112
+1
+0.9% +$82 0.01% 288
2024
Q1
$9.66K Buy
111
+1
+0.9% +$85 0.01% 283
2023
Q4
$9.06K Buy
110
+1
+0.9% +$76 0.01% 280
2023
Q3
$8.53K Buy
109
+1
+0.9% +$84 0.01% 266
2023
Q2
$9.52K Buy
108
+1
+0.9% +$86 0.01% 270
2023
Q1
$8.64K Buy
107
+1
+0.9% +$82 0.01% 226
2022
Q4
$8.26K Buy
106
+1
+1% +$81 0.01% 222
2022
Q3
$8.51K Hold
105
0.01% 211
2022
Q2
$9.39K Buy
105
+1
+1% +$101 0.01% 203
2022
Q1
$11.5K Buy
104
+1
+1% +$106 0.01% 203
2021
Q4
$10.7K Buy
+103
New +$11.9K 0.01% 205

Other funds holding MDT

PFS Partners's MDT Position: Q2 2026 in Review

PFS Partners reduced its Medtronic (MDT) stake by 20% in Q2 2026, selling an estimated $3.06K and leaving 156 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #362.

PFS Partners first reported a position in MDT in Q4 2021 and has held it in 19 quarters since. The position peaked at $22.3K in Q4 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • PFS Partners held 156 shares of Medtronic worth $12.2K as of Q2 2026.
  • PFS Partners sold 38 Medtronic shares in Q2 2026, an estimated $3.06K.
  • Medtronic made up ﹤0.01% of PFS Partners's portfolio in Q2 2026, its #362 holding.
  • PFS Partners first reported a position in Medtronic in Q4 2021 and has held it in 19 quarters since.
  • PFS Partners's Medtronic position peaked at $22.3K in Q4 2025.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.